嵌入式給藥設備的全球市場：產品類型、技術、應用、區域規模、份額、前景、機會分析（2022-2028）

植入式裝置可以與藥物結合，將藥物輸送到主要作用部位。出於這個原因，已經開發了許多藥物療法，包括激素疾病、心血管疾病、腫瘤和眼科。預計在預測期內，產品發布的增加也將推動全球植入式給藥裝置市場的增長。

本報告研究和分析全球嵌入式給藥設備市場，並提供有關市場動態、細分市場分析、區域市場分析、競爭狀況等方面的系統信息。

目錄

第 1 章調查目標/先決條件

• 調查目的
• 先決條件
• 縮寫

第二章市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
  • 市場細分：按產品類型
  • 市場細分：按技術分類
  • 市場細分：按用途
  • 市場細分：按最終用戶

第三章市場動態、法規、趨勢分析

• 市場動態
  • 促進因素
  • 抑制器
  • 市場機會
• 監管場景
• 行業趨勢
• 合併/收購
• 新產品的批准/發布
• 技術演進

第 4 章全球嵌入式給藥裝置市場：按產品類型（2017-2028）

• 簡介
• 藥物注射泵
• 眼內給藥裝置
• 避孕給藥裝置
• 支架

第 5 章全球嵌入式給藥裝置市場：按技術（2017-2028 年）

• 簡介
• 可生物降解植入物
• 不可生物降解的植入物

第 6 章全球嵌入式給藥裝置市場：按應用（2017-2028）

• 簡介
• 腫瘤學
• 心血管
• 避孕/避孕方法
• 其他

第 7 章全球嵌入式給藥裝置市場：按地區（2017-2028 年）

• 簡介
• 北美
• 歐洲
• 亞太地區
• 拉丁美洲
• 中東
• 非洲

第8章競爭態勢

• 熱圖分析
• 公司簡介
  • Merck & Co.
  • Bausch & Lomb Inc.
  • Medtronic Inc.
  • Allergan, Inc.
  • Psivida Corp.
  • Bayer Healthcare
  • Boston Scientific Corporation
  • Abbott Laboratories
• 分析師見解

第9章 章節

Implantable drug delivery devices, also called as implantable drug eluting devices, allow targeted and localized drug delivery once the device is implanted in the body. There are various implantable drug delivery devices available such as vascular stents, electro stimulation devices, orthopedic devices, and others. An implantable device also delivers drugs to the primary site of action, when it is combined with the drugs. Thus, many drug therapies have been developed for hormonal disorders, cardiovascular disorders, oncology, ophthalmology, and others.

There are two types of drug delivery systems: biodegradable and non-biodegradable. Biodegradable drug-eluting devices (also referred to as bioerodible) use biocompatible materials such as polyesteramide (PEA) and Poly Lactic-co-Glycolic Acid (PLGA) to deliver drugs and once implanted, it decomposes over time. On the other hand, non-biodegradable drug-eluting devices (also referred to as biodurable) use biocompatible materials such as silicone rubber (polydimethylsiloxane or PDMS), polyethylene-vinyl acetate (EVA), and thermoplastic polyurethane (TPU) to deliver drugs. Non-biodegradable drug-eluting devices can be refilled with medication (eg, via injection) and the device's effects are almost immediately reversible upon removal.

Market Dynamics

Increasing product launches is expected to drive the global implantable drug delivery devices market growth over the forecast period. For instance, in 2021, Occular Therapeutics launched Dextenza ophthalmic insert in the U.S. market. Dextenza ophthalmic insert is an ocular insert that is designed to release 0.4 mg of dexamethasone to relieve pain after ophthalmic surgery. It can deliver drugs for up to 30 days after treatment in a physician's office.

Companies are engaged in receiving approvals from the regulatory authorities for further marketing the products in the global market. For instance, in 2018, United Therapeutics Corporation received the U.S Food and Drug Administration (FDA) approval for the use of Remodulin (treprostinil) injection in the implantable system. In the Remodulin implantable system, the entire delivery system is implanted into the patient's body and the system is refilled by healthcare professionals at an interval of up to 16 weeks depending on the prescribed dose, by using a syringe needle and through the patient's skin.

Key features of the study:

• This report provides an in-depth analysis of global implantable drug delivery devices market, provides market size (US$ 12,015.2 Million), and compound annual growth rate (CAGR 7.7 %) for the forecast period (2022 - 2028), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global implantable drug delivery devices market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include Boston Scientific Corporation, Abbott Laboratories, Medtronic, Merck & Co., Bausch & Lomb Inc., Allergan, Inc., Psivida Corp., Bayer Healthcare, Alimera Sciences, Eyepoint Pharmaceuticals, Valeant Pharmaceuticals, DSM Biomedical, Delpor Inc., Teleflex Incorporated, and 3M Company
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global implantable drug delivery devices market report caters to various stakeholders in this industry including investors, suppliers, implantable drug delivery device manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision making through various strategy matrices used in analyzing the implantable drug delivery devices market

Detailed Segmentation:

• Global Implantable Drug Delivery Devices Market, By Product Type:
• Drug infusion pumps
• Intraocular drug delivery devices
• Contraceptive drug delivery devices
• Stents
• Global Implantable Drug Delivery Devices Market, By Technology:
• Biodegradable Implants
• Non-biodegradable Implants
• Global Implantable Drug Delivery Devices Market, By Application:
• Ophthalmology
• Oncology
• Cardiovascular
• Birth control/Contraception
• Others
• Global Implantable Drug Delivery Devices Market, By Region:
• North America

? By Country

? U.S.

? Canada

? By Product Type:

? Drug infusion pumps

? Intraocular drug delivery devices

? Contraceptive drug delivery devices

? Stents

? By Technology

? Biodegradable Implants

? Non-biodegradable Implants

? By Application

? Ophthalmology

? Oncology

? Cardiovascular

? Birth control/Contraception

? Others

• Europe

? By Country:

? U.K.

? Germany

? Italy

? Spain

? France

? Russia

? Rest of Europe

? By Product Type:

? Drug infusion pumps

? Intraocular drug delivery devices

? Contraceptive drug delivery devices

? Stents

? By Technology

? Biodegradable Implants

? Non-biodegradable Implants

? By Application

? Ophthalmology

? Oncology

? Cardiovascular

? Birth control/Contraception

? Others

• Asia Pacific

? By Country:

? Australia

? India

? China

? Japan

? ASEAN

? South Korea

? Rest of Asia Pacific

? By Product Type:

? Drug infusion pumps

? Intraocular drug delivery devices

? Contraceptive drug delivery devices

? Stents

? By Technology

? Biodegradable Implants

? Non-biodegradable Implants

? By Application

? Ophthalmology

? Oncology

? Cardiovascular

? Birth control/Contraception

? Others

• Latin America

? By Country:

? Brazil

? Mexico

? Argentina

? Rest of Latin America

? By Product Type:

? Drug infusion pumps

? Intraocular drug delivery devices

? Contraceptive drug delivery devices

? Stents

? By Technology

? Biodegradable Implants

? Non-biodegradable Implants

? By Application

? Ophthalmology

? Oncology

? Cardiovascular

? Birth control/Contraception

? Others

• Middle East

? By Country:

? GCC

? Israel

? Rest of Middle East

? By Product Type:

? Drug infusion pumps

? Intraocular drug delivery devices

? Contraceptive drug delivery devices

? Stents

? By Technology

? Biodegradable Implants

? Non-biodegradable Implants

? By Application

? Ophthalmology

? Oncology

? Cardiovascular

? Birth control/Contraception

? Others

• Africa

? By Country/Region:

? South Africa

? Central Africa

? North Africa

? By Product Type:

? Drug infusion pumps

? Intraocular drug delivery devices

? Contraceptive drug delivery devices

? Stents

? By Technology

? Biodegradable Implants

? Non-biodegradable Implants

? By Application

? Ophthalmology

? Oncology

? Cardiovascular

? Birth control/Contraception

? Others

• Company Profiles
• Boston Scientific Corporation

? Company Overview

? Product Portfolio

? Financial Performance

? Recent Highlights

? Strategies

• Abbott Laboratories
• Medtronic, Merck & Co.
• Bausch & Lomb Inc.
• Allergan, Inc.
• Bayer Healthcare
• Alimera Sciences
• Eyepoint Pharmaceuticals
• DSM Biomedical
• Delpor Inc.
• Teleflex Incorporated
• 3M Company

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet By Product Type
  • Market Snippet By Technology
  • Market Snippet By Application
  • Market Snippet By End User
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Regulatory Scenario
• Industry Trend
• Merger and Acquisitions
• New Product Approvals/Launch
• Technology Evolution

4. Global Implantable Drug Delivery Devices Market, By Product Type, 2017 - 2028 (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-O-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Drug infusion pumps
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
• Intraocular drug delivery devices
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
• Contraceptive drug delivery devices
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
• Stents
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)

5. Global Implantable Drug Delivery Devices Market, By Technology, 2017 - 2028 (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-O-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Biodegradable Implants
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
• Non-Biodegradable Implants
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)

6. Global Implantable Drug Delivery Devices Market, By Application, 2017 - 2028 (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-O-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
• Cardiovascular
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
• Birth control/Contraception
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)

7. Global Implantable Drug Delivery Devices Market, By Regions, 2017 - 2028 (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
  • Regional Trends
• North America
  • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
  • U.S.
  • Canada
• Europe
  • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of APAC
• Latin America
  • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East
  • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
  • South Africa
  • Central Africa
  • North Africa

8. Competitive Landscape

• Heat Map Analysis
• Company Profiles
  • Merck & Co.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Future Plans
  • Bausch & Lomb Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Future Plans
  • Medtronic Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Future Plans
  • Allergan, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Future Plans
  • Psivida Corp.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Future Plans
  • Bayer Healthcare
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Future Plans
  • Boston Scientific Corporation
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Future Plans
  • Abbott Laboratories
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Future Plans
• Analyst Views

9. Section

• References
• Research Methodology
• About us and Sales Contact